Tesla will stop making two of its popular cars to use the production line to manufacture Optimus humanoid robots. Elon Musk, Tesla’s CEO, announced that it is time to kill off two models, which have ...

Tesla plans to end production of its Model S and Model X vehicles in the spring. The company will convert the factory space to build its Optimus robot. CEO Elon Musk stated the move is part of a shift ...

Tesla Optimus humanoid robot being displayed at the company's flagship store - Teo K/Shutterstock During Tesla's earnings call for the 2025 fiscal year, the company's CEO Elon Musk announced that the ...

Tesla (TSLA) CEO Elon Musk, who turned an upstart electric vehicle maker into an industry-changing powerhouse, is pulling the plug on the two models that helped get him there, as he struggles with ...

Tesla CEO Elon Musk said Wednesday that the company would begin phasing out its Model S and Model X electric vehicles this year and retool a California factory to produce humanoid robots instead. The ...

Tesla is ending production of the Model S sedan and Model X SUV, CEO Elon Musk announced Wednesday during the company’s quarterly earnings call. The company will make the final versions of both ...

Understanding human gene function in living organisms has long been hampered by fundamental differences between species. Although mice share most protein-coding genes with humans, their regulatory ...

Rei is the Deputy Lead for GameRant's Anime Team from Kashmir, situated in Beirut. He's an avid fan of anime and manga. Rei grew up watching anime and had a knack for writing ever since he was a kid, ...

Santa’s little spy went from shelf to scorched. One mom had a holiday meltdown this week after accidentally “roasting” her daughter’s Elf on the Shelf — and nearly igniting Christmas chaos in the ...

Twin sisters Chanda Bell and Christa Pitts grew up with a family tradition that is now a booming business. They, along with their mother Carol Aebersold, are the creators of The Elf on the Shelf, a ...

CMS has proposed two new models aimed at curbing Medicare drug spending by linking payments to international benchmarks. The proposals — GUARD for Part D drugs and GLOBE for Part B — are the latest in ...